Skip to content

Cannabis: all studies

Page 110 of 287: studies 1,091 to 1,100 of 2,868, newest first. Back to the cannabis overview

Research

Recommendation to reconsider examining cannabis subtypes together due to opposing effects on brain, cognition and behavior

Neuroscience & Biobehavioral Reviews June 1, 2017 Kristine Rømer Thomsen, M. B. Callesen, S. W. F. Ewing

Cannabis use represents a major public health issue throughout the globe. Yet, we still lack the most fundamental knowledge on long-term effects of cannabis on neural, cognitive, and behavioral function. Part of this stems from how cannabis has been measured historically. To this end, most empirical examinations of cannabis have consolidated all types of cannabis collectively. However, this...

The relationship between cannabis use and cortisol levels in youth at ultra high-risk for psychosis

Psychoneuroendocrinology May 30, 2017 E. Carol, R. L. Spencer, V. Mittal

Recent studies have posited a relationship between cannabis use and the biological stress system, but this critical relationship has not been evaluated during the ultra high-risk (UHR) period immediately preceding the onset of psychotic disorders. Salivary cortisol samples were collected on 46 UHR and 29 control adolescents; these individuals were assessed for current cannabis use with a urine...

Acute memory and psychotomimetic effects of cannabis and tobacco both ‘joint’ and individually: a placebo-controlled trial

Psychological Medicine May 30, 2017 Chandni Hindocha, Tom P. Freeman, Joanna Xia et al. 104 citations

BACKGROUND: Cannabis and tobacco have contrasting cognitive effects. Smoking cannabis with tobacco is prevalent in many countries and although this may well influence cognitive and mental health outcomes, the possibility has rarely been investigated in human experimental psychopharmacological research. METHOD: The individual and interactive effects of cannabis and tobacco were evaluated in 24...

Cannabis exacerbates depressive symptoms in rat model induced by reserpine.

Behavioural Brain Research May 1, 2017 Yasser A Khadrawy, Hussein G Sawie, Omar M E Abdel-Salam et al.

Cannabis sativa is one of the most widely recreational drugs and its use is more prevalent among depressed patients. Some studies reported that Cannabis has antidepressant effects while others showed increased depressive symptoms in Cannabis users. Therefore, the present study aims to investigate the effect of Cannabis extract on the depressive-like rats. Twenty four rats were divided into:...

Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition

Current Addiction Reports April 29, 2017 Marco Colizzi, Sagnik Bhattacharyya

Purpose of ReviewThe lack of clarity about the effect of cannabis use on cognition may be attributable to the considerable heterogeneity among studies in terms of cannabis composition. This article selectively reviews studies examining the distinctive effects of cannabinoids on human cognition, particularly those of delta-9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD).Recent...

Cognitive Functioning of Adolescent and Young Adult Cannabis Users in the Philadelphia Neurodevelopmental Cohort

Psychology of Addictive Behaviors April 17, 2017 J. Scott, Daniel H. Wolf, Monica E. Calkins et al.

Cannabis use in youth is rising and has been linked to deficits in cognitive functioning. However, cognitive findings have primarily been based on small samples of users seeking treatment, and few studies have evaluated cognition in occasional cannabis users. Here, we examined 4,568 adolescents and young adults (ages 14–21 years) drawn from the Philadelphia Neurodevelopmental Cohort, a...

Mechanisms Contributing to Cognitive Deficits in Cannabis Users

Neuropharmacology April 14, 2017 Romina Mizrahi, Jeremy J. Watts, Kuei Yuan Tseng

Studies from preclinical animal models indicate that sustained activation of CB1 receptor signaling is a major contributing factor for the onset of cognitive deficits associated to chronic cannabis use, in particular within the working memory and decision-making domains. Yet, very few studies have been designed to directly assess the role of CB1 receptors in mediating the effects of cannabis on...

Psychosis – Different presentation for designer drugs compared to cannabis abusers?

European Psychiatry April 1, 2017 F. Dumitrescu

Introduction: “Bath salts” target the endocannabinoid system in a similar manner to cannabis. In the case of designer drug misuse, subjects seem to be at higher risk of psychotic symptoms. Aims: To investigate the nature and frequency of psychotic symptoms associated with cannabis and/or bath salts misuse in a male inpatient population. Method: The files of 107 patients admitted to the...

The impact of Cannabis in Schizophrenia: Pafip Three-year Longitudinal Study on Outcome and Functionality After a First Episode of Psychosis

European Psychiatry April 1, 2017 M. Gomez Revuelta, María Juncal Ruiz, O. Porta Olivares et al.

Introduction The association between cannabis and psychosis makes crucial the intervention on cannabis use disorder at first episodes of psychosis (FEP), especially among young population. In this group of patients, the harmful potential of cannabis is more evident by its influence on neurodevelopment. However, the nature of the association cannabis-psychosis is not clearly described. It seems...

Comparative examination of the differences between cannabis psychosis and methamphetamine psychosis in a psychological state

European Psychiatry April 1, 2017 A. Oda

BackgroundWith the rapid and intensive spread of marihuana abuse among youth, Japanese society is focusing on law enforcement against drug abusers. In 2016, a mass killing allegedly committed by a marihuana abuser was reported in Japan.ObjectivesTo consider that common recognition of the diverse process and potential risks of cannabis psychosis should be shared among psychiatrists.AimsElicit...